Anti-LINGO-1 trial results
A phase 2 study involving 82 people found that repair of myelin on the optic nerve was better in people taking a drug called anti-LINGO-1 than in a group taking a placebo. Further trials are planned.
Biogen press release
Daily Telegraph
Forbes
Latest MS research update
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news